GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...

Monthly Tezepelumab injections helped 90% of severe asthma patients cut steroid use, with many seeing improved symptoms and fewer ER visits.

Early-life RSV infection and parental allergy interact to substantially increase childhood asthma risk, supported by ...

Why do certain immune cells remain permanently active in allergic asthma—even in an environment that should actually damage ...

Scientists found that RSV infection early in life can set the stage for childhood asthma, particularly in kids already ...

Personal narratives on allergy and asthma conditions which contained inaccuracies gained the most traction online.

Objective Systemic corticosteroids for 5–7 days are standard care for asthma exacerbations, but the optimal duration and ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

New research from the University of Vermont reveals exposure to smoke from Canadian wildfires in the summer of 2023 led to ...

The Ministry of Public Health (MOPH) has recently organised a training workshop for around 90 health service providers from ...

New research from the University of Vermont reveals exposure to smoke from Canadian wildfires in the summer of 2023 led to ...